Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Type 2 Diabetes; Hypogonadism
Intervention: Drug: Testosterone
Sponsor: Tameside Hospital NHS Foundation Trust
Not yet recruiting - verified November 2008
Condition: HIV Infections
Interventions: Biological: HIV-v (Low Dose); Biological: HIV-v (High Dose); Biological: HIV-v (Control)
Sponsor: PepTcell Limited
Recruiting - verified February 2010
Conditions: HIV; HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
Sponsor: St Stephens Aids Trust
Not yet recruiting - verified February 2010
Condition: HIV Infections
Intervention: Drug: TMC278LA
Sponsor: St Stephens Aids Trust
Recruiting - verified March 2010
Condition: Erectile Dysfunction
Interventions: Drug: Tadalafil; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Conditions: HIV Infections; HIV-1
Intervention: Drug: Etravirine
Sponsor: Tibotec Pharmaceuticals, Ireland
Recruiting - verified February 2010
Condition: HIV Infections
Interventions: Drug: darunavir tablets; Drug: ritonavir capsule
Sponsors: Tibotec Pharmaceuticals, Ireland; Tibotec Pharmaceuticals
Recruiting - verified February 2010
Conditions: Bladder Cancer; Brain and Central Nervous System Tumors; Esophageal Cancer; Intraocular Melanoma; Kidney Cancer; Lymphoma; Melanoma (Skin); Pancreatic Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions: Genetic: DNA analysis; Genetic: polymorphism analysis; Other: laboratory biomarker analysis; Other: questionnaire administration
Sponsor: Cancer Research UK
Recruiting - verified September 2008
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen; Drug: Optimized background antiretroviral drug regimen without maraviroc
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Drug: maraviroc
Sponsor: Pfizer
Recruiting - verified February 2010
Condition: Breast Cancer
Interventions: Drug: exemestane; Drug: tamoxifen citrate; Drug: triptorelin; Procedure: oophorectomy; Radiation: radiation therapy
Sponsors: International Breast Cancer Study Group; National Cancer Institute (NCI); Breast International Group; Cancer and Leukemia Group B; NCIC Clinical Trials Group; North Central Cancer Treatment Group; National Surgical Adjuvant Breast and Bowel Project (NSABP); Southwest Oncology Group
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Drug: Tipranavir
Sponsor: Boehringer Ingelheim Pharmaceuticals
Available - verified March 2010